NasdaqGM - Nasdaq Real Time Price USD
ArriVent BioPharma, Inc. (AVBP)
21.08
+0.80
+(3.94%)
At close: April 23 at 4:00:01 PM EDT
20.80
-0.28
(-1.33%)
Pre-Market: 4:26:55 AM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
Operating Cash Flow
-70,212
-70,212
-55,842
-43,631
Investing Cash Flow
-192,465
-192,465
--
--
Financing Cash Flow
186,581
186,581
42,859
169,723
End Cash Position
74,293
74,293
150,389
163,372
Issuance of Capital Stock
185,950
185,950
44,919
169,708
Free Cash Flow
-70,212
-70,212
-55,842
-43,631
12/31/2022 - 1/26/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BCAX Bicara Therapeutics Inc.
15.51
+12.23%
ARTV Artiva Biotherapeutics, Inc.
2.4500
0.00%
CTNM Contineum Therapeutics, Inc.
4.7400
-3.27%
MAZE Maze Therapeutics, Inc.
9.55
-3.14%
MBX MBX Biosciences, Inc.
8.99
+4.05%
CGON CG Oncology, Inc.
20.73
+1.22%
603233.SS DaShenLin Pharmaceutical Group Co., Ltd.
17.46
+0.34%
1OT.F Ovid Therapeutics Inc.
0.2260
+15.31%
UCB.VI UCB SA
146.05
0.00%
RFM.F Sensorion SA
0.1210
-13.57%